美股期权个股详情

NGNE240920P45000

添加自选
  • 0.00
  • 0.000.00%
延时15分钟行情收盘价 09/27 09:30 (美东)
0.00最高价0.00最低价

Neurogene股票讨论

登录发表评论
    Jaguar8
    Jaguar8
    04/23 04:37
    $Neurogene (NGNE.US)$
    NEWS
    Neurogene Announces Upcoming Presentation of Safety Data from Phase 1/2 Trial of NGN-401 Gene Therapy for Rett Syndrome at ASGCT Meeting
    NEW YORK--(BUSINESS WIRE)-- Neurogene Inc. (Nasdaq: NGNE), a clinical-stage company founded to bring life-changing genetic medicines to patients and families affected by rare neurological diseases, today announced that initial safety and tolerability data from its ongoing Phase 1/2 gene therapy clinical trial for Rett syndrome will be ...

暂无评论